了解医学学生的知识,态度和准备需求,以便在未来处方长效注射性暴露前预防药物
Kenneth Cole1,2, Jacob Bleasdale3, Amy Hequembourg1
1University at Buffalo, Buffalo, NY USA.
Discover public health
|November 13, 2025
概括
医学学生对注射性暴露前预防 (PrEP) 用于预防人类免疫缺陷病毒 (HIV) 的认识较低. 他们希望全面的教育和沟通技巧培训能够有效地规定这种新型的艾滋病毒预防方法.
科学领域:
- 医学教育 医学教育
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 注射式暴露前预防 (PrEP) 提出了预防人类免疫缺陷病毒 (HIV) 的新策略.
- 有效地实施注射PrEP取决于医疗保健提供者的知识和意识.
- 将注射PrEP教育纳入医疗课程可以提高未来提供者准备.
研究的目的:
- 评估医学学生对注射PrEP的看法和态度.
- 为未来的医疗保健提供者确定关于注射PrEP处方的教育需求.
- 为制定针对HIV预防的有针对性的教育干预措施提供信息.
主要方法:
- 在2022年6月至8月期间,对32名医学学生进行了深入的半结构面试.
- 采用主题分析来识别学生感知和教育需求中的关键主题.
- 专注于了解学生准备好开处方注射PrEP的情况.
主要成果:
- 在医学学生中发现注射PrEP的认识和知识较低.
- 对可注射PrEP的可获得性提出了担忧.
- 突出了学生对以患者为中心的好处,沟通技巧和可注射PrEP的全面处方教育的兴趣.
结论:
- 医学学生表达了需要特定的,以患者为中心的教育机会,以处方注射PrEP.
- 解决这些教育差距对于成功实施注射PrEP至关重要.
- 开发创新的培训计划对于加强艾滋病毒预防和治疗教育至关重要.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
242
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
242
Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248


